🇺🇸 Fentanyl infusion in United States

60 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Blood Creatinine Increased — 10 reports (16.67%)
  2. Alanine Aminotransferase Increased — 9 reports (15%)
  3. Aspartate Aminotransferase Increased — 9 reports (15%)
  4. Hypotension — 7 reports (11.67%)
  5. Acute Kidney Injury — 6 reports (10%)
  6. Glomerular Filtration Rate Decreased — 4 reports (6.67%)
  7. Hypoxia — 4 reports (6.67%)
  8. Shock — 4 reports (6.67%)
  9. Therapy Cessation — 4 reports (6.67%)
  10. Acute Respiratory Distress Syndrome — 3 reports (5%)

Source database →

Fentanyl infusion in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Fentanyl infusion approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Fentanyl infusion in United States?

Ain Shams University is the originator. The local marketing authorisation holder may differ — check the official source linked above.